ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,074Medicare Part D Prescriptions Filled, Including Refills

Rank: 948 out of 6782

$684K Total Retail Price of All Prescriptions

Rank: 803 out of 6782

429 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 429 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

15% of this provider’s 429 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
ATORVASTATIN CALCIUM 461 436 83 1 5
LEVOTHYROXINE SODIUM 454 403 68 2 3
OMEPRAZOLE 391 320 75 3 7
AMLODIPINE BESYLATE 349 336 62 4 2
LISINOPRIL 314 278 53 5 4
FENTANYL CITRATE 296 <11 <11 S2 10 6 509
ALPRAZOLAM 265 222 50 B 7 37
METFORMIN HCL ER 252 221 40 8 82
HYDROCODONE-ACETAMINOPHEN 247 184 53 S3 9 6
SIMVASTATIN 245 214 41 10 1
ZOLPIDEM TARTRATE 237 154 43 11 18
LOSARTAN POTASSIUM 192 173 36 12 10
DONEPEZIL HCL 176 176 28 13 31
METFORMIN HCL 169 157 33 14 8
DIOVAN 158 142 23 15 26
HYDROCHLOROTHIAZIDE 155 135 24 16 12
NAMENDA 146 146 15 17 36
CRESTOR 141 123 31 18 38
ALENDRONATE SODIUM 126 93 22 19 14
METOPROLOL SUCCINATE 123 118* 22 20 22
LOSARTAN-HYDROCHLOROTHIAZIDE 122 111 18 21 51
FLUTICASONE PROPIONATE 114 95 46 22 24
VALSARTAN-HYDROCHLOROTHIAZIDE 107 102* 20 23 75
JANUVIA 105 75 16 24 40
CITALOPRAM HBR 96 96 11 25 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 88 83* 18 26 41
ZETIA 86 86 20 27 85
BYSTOLIC 85 85 14 28 100
PIOGLITAZONE HCL 84 63 12 R 29 65
ESCITALOPRAM OXALATE 82 66 15 30 53
FUROSEMIDE 81 76* 21 31 11
CARVEDILOL 77 72* 18 32 23
GABAPENTIN 76 57 19 33 15
TRAZODONE HCL 73 68* 19 34 50
TAMSULOSIN HCL 70 70 16 35 21
MIRTAZAPINE 68 63* 12 36 72
JANUMET 66 48 12 37 129
TRAMADOL HCL 63 52 18 38 32
NAPROXEN 57 <11 <11 39 92
ADVAIR DISKUS 57 52* 13 39 49
BUPROPION XL 52 <11 <11 41 185
SPIRIVA 52 <11 <11 41 61
PRAVASTATIN SODIUM 51 <11 <11 43 20
DOXAZOSIN MESYLATE 51 <11 <11 43 87
SPIRONOLACTONE-HCTZ 50 <11 <11 45 294
FLUOXETINE HCL 50 37 11 45 64
LORAZEPAM 50 27 14 B 45 29
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.